Newsletter
Earnings
Interviews
Transcripts
×
Menu
Home
Earnings
Interviews
Transcripts
IPO
Tech
REGN
Transcript
Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Transcript
February 2, 2026
Regeneron Full Year Revenue Totals $14.34 Billion
January 30, 2026
Top